[{"type": "title", "data": "OB AMB Induction and Cervical Ripening with Prostaglandin (Multiphase)"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Nurse to initiate the First Induction phase of this PowerPlan", "value": ""}, {"type": "note", "data": "Refer to Society of Obstetricians and Gynaecologists of Canada (SOGC) Clinical Practice Guideline Induction of Labour", "value": ""}, {"type": "order", "data": "Discharge Patient Criteria", "value": "checked"}, {"type": "sentence", "data": "Discharge after one hour of electronic fetal monitoring if: woman is not in active labour, discharge instructions given, and non-stress test is normal"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "once, on admission"}, {"type": "order", "data": "Fetal Non-Stress Test (NST) - Inpatient", "value": "checked"}, {"type": "sentence", "data": "Routine, Reason: Pre Cervical Ripening Assessment, once"}, {"type": "order", "data": "Assess Uterine Contractions", "value": "checked"}, {"type": "sentence", "data": "Assess q15min for 1 hour post administration of prostaglandin"}, {"type": "order", "data": "Electronic Fetal Monitoring", "value": "checked"}, {"type": "sentence", "data": "Continuous for 1 hour post administration of prostaglandin"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "order", "data": "NPO", "value": "checked"}, {"type": "sentence", "data": "No Exceptions, for 1 hour post administration of prostaglandin"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Prostaglandin should not be used in the setting of trial of labour after cesarean section in the third trimester with a live fetus (risk of uterine rupture)", "value": ""}, {"type": "order", "data": "dinoprostone vaginal", "value": "checked"}, {"type": "sentence", "data": "10 mg, vaginal, once, drug form: insert"}, {"type": "order", "data": "dinoprostone vaginal 1 mg/2.5 mL gel", "value": ""}, {"type": "sentence", "data": "1 application, vaginal, once, drug form: gel"}, {"type": "order", "data": "dinoprostone vaginal 2 mg/2.5 mL gel", "value": ""}, {"type": "sentence", "data": "1 application, vaginal, once, drug form: gel"}, {"type": "order", "data": "nitroglycerin 0.4 mg/spray spray", "value": "checked"}, {"type": "sentence", "data": "1 spray, sublingual, as directed, PRN other (see comment), drug form: spray"}, {"type": "note", "data": "Do not start oxytocin induction for at least 30 minutes after removal of the last dinoprostone vaginal insert (CERVIDIL)", "value": ""}, {"type": "note", "data": "Do not start oxytocin induction for at least 6 hours after dinoprostone gel administration", "value": ""}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "Nurse to initiate the Second Induction phase of this PowerPlan", "value": ""}, {"type": "note", "data": "Refer to Society of Obstetricians and Gynaecologists of Canada (SOGC) Clinical Practice Guideline Induction of Labour", "value": ""}, {"type": "order", "data": "Discharge Patient Criteria", "value": "checked"}, {"type": "sentence", "data": "Discharge after one hour of electronic fetal monitoring if: woman is not in active labour, discharge instructions given, and non-stress test is normal"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Nurse to Discontinue Order Set/Phase", "value": "checked"}, {"type": "sentence", "data": "Nurse to discontinue the First Induction phase of this PowerPlan if applicable"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "once, on admission"}, {"type": "order", "data": "Fetal Non-Stress Test (NST) - Inpatient", "value": "checked"}, {"type": "sentence", "data": "Routine, Reason: Pre Cervical Ripening Assessment, once"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Ensure previously inserted dinoprostone vaginal insert (CERVIDIL) has been removed"}, {"type": "order", "data": "Assess Uterine Contractions", "value": "checked"}, {"type": "sentence", "data": "Assess q15min for 1 hour post administration of prostaglandin"}, {"type": "order", "data": "Electronic Fetal Monitoring", "value": "checked"}, {"type": "sentence", "data": "Continuous for 1 hour post administration of prostaglandin"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "order", "data": "NPO", "value": "checked"}, {"type": "sentence", "data": "No Exceptions, for 1 hour post administration of prostaglandin"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Prostaglandin should not be used in the setting of trial of labour after cesarean section in the third trimester with a live fetus (risk of uterine rupture)", "value": ""}, {"type": "order", "data": "dinoprostone vaginal", "value": "checked"}, {"type": "sentence", "data": "10 mg, vaginal, once, drug form: insert"}, {"type": "order", "data": "dinoprostone vaginal 1 mg/2.5 mL gel", "value": ""}, {"type": "sentence", "data": "1 application, vaginal, once, drug form: gel"}, {"type": "order", "data": "dinoprostone vaginal 2 mg/2.5 mL gel", "value": ""}, {"type": "sentence", "data": "1 application, vaginal, once, drug form: gel"}, {"type": "order", "data": "nitroglycerin 0.4 mg/spray spray", "value": "checked"}, {"type": "sentence", "data": "1 spray, sublingual, as directed, PRN other (see comment), drug form: spray"}, {"type": "note", "data": "Do not start oxytocin induction for at least 30 minutes after removal of the last dinoprostone vaginal insert (CERVIDIL)", "value": ""}, {"type": "note", "data": "Do not start oxytocin induction for at least 6 hours after dinoprostone gel administration", "value": ""}]
